Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Dermatology

What Is the Link Between BP and Neurological Disorders?

At a Glance

Bullous pemphigoid is most strongly associated with Parkinson’s disease and dementia, but an association does not prove one causes the other. Researchers are studying whether shared proteins in the skin and nervous system help explain why some people develop both conditions.

It can be surprising to hear that a skin blistering condition like bullous pemphigoid (BP) is connected to a neurological condition like Parkinson’s disease. However, research shows that BP is associated with several neurological disorders. The strongest and most consistently reported associations are with dementia and Parkinson’s disease, though links to stroke and multiple sclerosis have also been observed in some studies [1][2].

The connection involves the immune system and two specific proteins: BP180 and BP230. In the skin, these proteins act like anchors, holding the top layers of skin to the bottom layers [3]. Bullous pemphigoid is an autoimmune disease, meaning the immune system mistakenly creates antibodies (immune proteins that recognize and neutralize targets) to attack these anchors. When the immune system attacks them, the skin separates, filling with fluid and creating tense blisters [4].

What researchers have discovered is that related forms of these same proteins also exist in the central nervous system and brain, where they help support the structure and stability of nerve cells [5][6][7].

The Cross-Reactivity Hypothesis: What Researchers Are Studying

Because these proteins exist in both the skin and the nervous system, researchers have proposed a hypothesis called cross-reactivity to explain why the two conditions might be linked [8].

According to this proposed theory, when a person has a neurological condition, nerve cells undergo damage. This damage might expose the nervous system’s versions of the BP180 and BP230 proteins to the immune system. The immune system might then register them as foreign invaders and develop antibodies against them. As these antibodies circulate through the body, they might eventually “cross-react” with the skin’s version of the proteins, leading to blisters [9].

It is important to understand that this is a research hypothesis, not a proven sequence of events. There is no single proven mechanism that fully explains the link between the brain and the skin. Not every patient with these antibodies develops skin blisters, and having antibodies in the blood does not automatically mean they will cause disease [10][11].

What This Means For You

If you have both BP and a neurological disorder like Parkinson’s disease, it is completely normal to have questions about what this means for your health:

  • Association does not equal causation: Having Parkinson’s disease does not mean it directly caused your BP, nor does having BP mean your neurological disease is worsening. The vast majority of people with Parkinson’s will never develop BP.
  • The timing varies: In many cases, the neurological disorder is diagnosed first, sometimes years before the skin blisters appear [12][13]. However, this timeline varies widely from person to person and does not prove that the neurological condition caused the blisters.
  • BP is not attacking your brain: The blisters are a skin condition. Developing BP does not mean the immune system is actively attacking your brain or central nervous system.
  • Watch for signs of infection: Widespread blisters, skin erosions, or fever warrant prompt medical assessment, especially if you have mobility or immune challenges.

Is It Caused by Medications?

When a new symptom appears, it is natural to wonder if a medication is to blame. Some drugs are known to trigger bullous pemphigoid—most notably certain diabetes medications called gliptins, and some diuretics [14].

Standard Parkinson’s disease medications, like levodopa or carbidopa, are generally not considered established causes of BP [15]. Because both your underlying conditions and your medications could be playing a role, your care team should perform a complete review of your prescription drugs, over-the-counter medicines, and supplements. Do not stop taking your Parkinson’s medication or any other prescribed drugs without your doctor’s guidance.

Common questions in this guide

Are bullous pemphigoid and Parkinson’s disease connected?
Studies have found an association between bullous pemphigoid and Parkinson’s disease, with a similarly strong reported association with dementia. This does not prove that Parkinson’s disease causes bullous pemphigoid, and most people with Parkinson’s disease will not develop it.
How could a neurological disorder be related to skin blisters?
Some proteins that help anchor skin cells also have related forms in the nervous system. Researchers propose that nerve-cell damage might expose these proteins to the immune system, leading to antibodies that also react with skin. This cross-reaction idea is still a hypothesis, not a proven explanation.
Does having bullous pemphigoid mean my immune system is attacking my brain?
No. Bullous pemphigoid is an autoimmune disease that causes blistering in the skin, and having it does not show that the brain or central nervous system is being attacked. The presence of related proteins in the nervous system is one reason researchers are studying the association.
Can Parkinson’s medicines or other drugs trigger bullous pemphigoid?
Certain diabetes medicines called gliptins and some diuretics are known to trigger bullous pemphigoid in some people. Levodopa and carbidopa are generally not considered established causes. Ask your care team to review all prescription medicines, over-the-counter products, and supplements, and do not stop prescribed treatment without medical guidance.
Which neurological conditions have been associated with bullous pemphigoid?
The most consistently reported associations are with dementia and Parkinson’s disease. Some studies have also observed links with stroke and multiple sclerosis, but these findings do not establish that any of these conditions directly causes bullous pemphigoid.
When do bullous pemphigoid blisters need prompt medical attention?
Widespread blisters, open areas where the skin has eroded, or fever should prompt medical assessment because damaged skin can become infected. Seek help promptly if mobility or immune problems make skin care more difficult.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Could any of my current medications, including those for Parkinson's or diabetes, be triggering my skin blisters, and if so, what are my alternatives?
  2. 2.Is there any evidence that my specific neurological history contributed to the development of my bullous pemphigoid?
  3. 3.Which BP treatment plan is safest for me given my risk of falls, swallowing difficulties, and general mobility issues?
  4. 4.How might my neurological condition affect the safety or side effects of systemic BP treatments (medicines that reduce inflammation throughout my body)?
  5. 5.How can we ensure that my neurologist and dermatologist are communicating effectively about my combined care plan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis.

    Lai YC, Yew YW, Lambert WC

    Journal of the European Academy of Dermatology and Venereology : JEADV 2016; (30(12)):2007-2015 doi:10.1111/jdv.13660.

    PMID: 27599898
  2. 2

    The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study.

    Kridin K, Hübner F, Recke A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(10)):2074-2078 doi:10.1111/jdv.17465.

    PMID: 34153122
  3. 3

    Life before and beyond blistering: The role of collagen XVII in epidermal physiology.

    Natsuga K, Watanabe M, Nishie W, Shimizu H

    Experimental dermatology 2019; (28(10)):1135-1141 doi:10.1111/exd.13550.

    PMID: 29604146
  4. 4

    Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.

    Bernard P, Antonicelli F

    American journal of clinical dermatology 2017; (18(4)):513-528 doi:10.1007/s40257-017-0264-2.

    PMID: 28247089
  5. 5

    Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease.

    Kokkonen N, Herukka SK, Huilaja L, et al.

    The Journal of investigative dermatology 2017; (137(1)):71-76 doi:10.1016/j.jid.2016.09.010.

    PMID: 27650606
  6. 6

    Functional and Genetic Analysis of Neuronal Isoforms of BPAG1.

    Lynch-Godrei A, Kothary R

    Methods in enzymology 2016; (569()):355-72.

    PMID: 26778567
  7. 7

    Roles of dystonin isoforms in the maintenance of neural, muscle, and cutaneous tissues.

    Yoshioka N

    Anatomical science international 2024; (99(1)):7-16 doi:10.1007/s12565-023-00739-1.

    PMID: 37603210
  8. 8

    A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?

    Amber KT, Zikry J, Hertl M

    HLA 2017; (89(3)):127-134 doi:10.1111/tan.12960.

    PMID: 28101965
  9. 9

    What's new in the pathogeneses and triggering factors of bullous pemphigoid.

    Ujiie H

    The Journal of dermatology 2023; (50(2)):140-149 doi:10.1111/1346-8138.16654.

    PMID: 36412277
  10. 10

    Neurological and psychiatric associations in bullous pemphigoid-more than skin deep?

    Försti AK, Huilaja L, Schmidt E, Tasanen K

    Experimental dermatology 2017; (26(12)):1228-1234 doi:10.1111/exd.13401.

    PMID: 28677172
  11. 11

    BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer's Disease than in Bullous Pemphigoid.

    Tuusa J, Lindgren O, Tertsunen HM, et al.

    The Journal of investigative dermatology 2019; (139(2)):293-299 doi:10.1016/j.jid.2018.09.010.

    PMID: 30315782
  12. 12

    The association between bullous pemphigoid and neurological disorders: a systematic review.

    Milani-Nejad N, Zhang M, Kaffenberger J

    European journal of dermatology : EJD 2017; (27(5)):472-481 doi:10.1684/ejd.2017.3066.

    PMID: 28681724
  13. 13

    Associations between bullous pemphigoid and comorbidities: A Swedish nationwide cohort study of 5,738 patients.

    Albadri Z, Häbel H, Thorslund K, et al.

    Journal of multimorbidity and comorbidity 2026; (16()):26335565261455676 doi:10.1177/26335565261455676.

    PMID: 42186604
  14. 14

    A Systematic Review of Drug-Induced Pemphigoid.

    Verheyden MJ, Bilgic A, Murrell DF

    Acta dermato-venereologica 2020; (100(15)):adv00224 doi:10.2340/00015555-3457.

    PMID: 32176310
  15. 15

    Autoimmunity to Collagen XVII (BP180-Ag2) in Pemphigoid Associated With Parkinson's Disease.

    Cid-Puente R, Ornelas-Ramírez IG, González-Herrera L, et al.

    Case reports in dermatological medicine 2026; (2026()):3649019 doi:10.1155/crdm/3649019.

    PMID: 41626532

This page is for informational purposes only and does not constitute medical advice. It cannot determine what caused your blisters; discuss your medications and care plan with your dermatologist and neurologist.

Get notified when new evidence is published on Bullous pemphigoid.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.